|Articles|August 1, 2002

Applied Clinical Trials

Applied Clinical Trials-08-01-2002

Developing New Drugs in 1000 Days

Everybody wants faster cycles and and quicker turnarounds with NDAs. In the U.S., will it soon be possible to go from testing to approval in 1000 days?

External Link - article-26825.pdf

Articles in this issue

about 24 years ago

Article

Cross-(Dys)Functional Teams

about 24 years ago

Article

Checking In on Children, Checking Up on Files

about 24 years ago

Article

about 24 years ago

Article

New User Fee Program Aims to Spur Drug Development

about 24 years ago

Article

Paper vs. Electronic Diaries

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

ACT Brief: Site Relationships and Payment Reliability, AI Adoption Without Governance Risk, and China's Biotech Innovation Rise

ByAndy Studna, Senior Editor

August 28th 2026

What Sponsors Stand to Lose If Site Payment Infrastructure Doesn't Improve

ByPatrick Mizer,Andy Studna, Senior Editor

August 27th 2026

Generative AI is moving faster than any technology shift in history—and sponsors and CROs that treat a powerful model as a strategy, rather than a governed, validated workflow, are gambling with patient safety and regulatory standing.

AI Is Moving Faster Than Any Technology Before It

August 27th 2026

ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems

ByAndy Studna, Senior Editor

August 27th 2026

A survey of 300 clinical operations executives conducted last year by Frost & Sullivan and sponsored by IQVIA found that the manual effort required to connect siloed systems and processes is the top challenge in clinical trial financials. Credit: Stock.Adobe.com/photon_photo.

From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance

ByRajesh Patel,Zahiah (Zee Zee) Gueddar

August 26th 2026

Trending on Applied Clinical Trials Online

AI Is Moving Faster Than Any Technology Before It

Where AI Is Delivering Real Value in Clinical Trial Payments Right Now

What Sponsors Stand to Lose If Site Payment Infrastructure Doesn't Improve

ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems

Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway